| Literature DB >> 27089920 |
Yuanzhao Zhu1, Junjun Zheng1, Ling Zhang1, Zhenguo Zeng2, Min Zhu1, Xiaobin Li1, Xiaoliang Lou3, Hui Wan1, Daojun Hong4.
Abstract
BACKGROUND: Reversible splenial lesion syndrome (RESLES) is a disorder radiologically characterized by reversible lesion in the splenium of the corpus callosum (SCC). Most of patients with RESLES associated with encephalitis/encephalopathy were identified in Japanese population, but almost no Chinese patients were diagnosed as RESLES associated with encephalitis/encephalopathy.Entities:
Keywords: Corpus callosum; Encephalitis; Encephalopathy; Poor outcome; Reversible splenial lesion syndrome
Mesh:
Year: 2016 PMID: 27089920 PMCID: PMC4835842 DOI: 10.1186/s12883-016-0572-9
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Fig. 1The cerebral MRI features of case 2. MRI revealed an isolated SCC lesion with obvious hyperintense on DWI (a, arrow), decreased ADC values (b), decreased fractional anisotropy value (c), and normally projecting direction of white matter fibers (f). At 16 days after initial MRI, second MRI showed the abnormalities of SCC nearly disappeared on DWI (d) and ADC (e)
Fig. 2The cerebral MRI features of case 7. MRI showed an isolated SCC lesion with slight hyperintense on T2WI (a), slight hypointense on T1WI (b), hyperintense on DWI (c, arrow), and obvious decreased ADC values (d). At 32 days after first MRI, second MRI showed abnormal signals of the SCC completely disappearing on T2WI (e), T1WI (f), DWI (g) and ADC (h)
Clinical data of patients with RESLES associated with encephalitis/encephalopathy
| patient no. | age/sex | initial symptom | CNS manifestation (onset day) | CNS diagnosis | EEG | CSF | pathogens | therapy | prognosis (day) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 15/M | fever | headache (2d) | encephalopathy | slow BA | normal | negative | None | CR (14d) |
| 2 | 23/M | fever, nasal congestion, pharyngalgia | headache, seizure, disturbance of consciousness, meningeal irritation sign (6d) | meningoencephalitis | NE | CC: 20 | influenza A | MPSL, IVIG, ACV, MV, CBZ, antibiotics, | vegetative state |
| 3 | 27/F | fever, cough | headache, ataxia, slurred language (2d) | encephalopathy | NE | normal | negative | Dex, ACV | CR (9d) |
| 4 | 38/M | fever, nasal congestion, cough | headache, vertigo (1d) | encephalopathy | NE | normal | herpesvirus-6 | ACV | CR (11d) |
| 5 | 26/M | fever, myalgias | headache, disturbance of consciousness (2d) | encephalitis | slow BA | CC:110 | negative | ACV, Dex, antibiotics | CR (10d) |
| 6 | 31/M | fever, pharyngalgia | vertigo (3d) | encephalopathy | slow BA | normal | negative | ACV, antibiotics | CR (20d) |
| 7 | 16/M | fever, cough | headache, delirious behavior, disturbance of consciousness (2d) | encephalitis | NE | CC: 15 | negative | MPSL, IVIG, ACV, MV, | agrypnocoma |
| 8 | 37/F | fever, myalgias | headache, tremor (1d) | encephalopathy | normal | normal | negative | None | CR (25d) |
| 9 | 25/F | fever, cough, pharyngalgia | headache, vertigo (3d) | encephalopathy | NE | normal | influenza B | ACV | CR(7d) |
| 10 | 30/M | fever | limb numbness, slurred language (2d) | encephalopathy | normal | normal | negative | None | CR(12d) |
| 11 | 30/F | fever, nasal congestion | headache, delirious behavior (5d) | encephalitis | normal | normal | EB virus | ACV, Dex | CR (7d) |
| 12 | 13/M | fever | headache, disturbance of consciousness, seizure, meningeal irritation sign (1d) | meningoencephalolitis | slow BA | CC: 73 | negative | ACV, PB, IVIG, antibiotics | CR (6d) |
| 13 | 33/F | none | vertigo | encephalopathy | normal | normal | negative | None | CR (14d) |
| 14 | 25/F | cough, pharyngalgia | headache (3d) | encephalopathy | NE | NE | negative | ACV | CR (10d) |
| 15 | 15/M | fever | headache (1d) | encephalitis | normal | CC: 19 | negative | ACV, Dex | CR (15d) |
CNS central nervous system, EEG electroencephalogram, CSF cerebrospinal fluid, BA basic activity, CR complete recovery, NE not examined, CC cell counting (cells/uL), MPSL methylprednisolone, IVIG intravenous immunoglobulin, ACV acyclovir, MV mechanical ventilation, CBZ carbamazepine, SL slurred language, Dex dexamethasone, PB phenobarbital
MRI characteristics of RESLES associated with encephalitis/encephalopathy
| patient no. | initial MRI | follow-up MRI | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| scan date1 | lesion | shape | T2WI | T1WI | Gd | DWI | ADC | DTI | scan date2 | scan date2 | |
| 1 | day 5 | SCC | ovoid | H | sL | NE | H | L | NE | day 12 | none |
| 2 | day 7 | SCC | extended | sH | sL | none | H | L | L | day 16 | none |
| 3 | day 4 | SCC | ovoid | H | L | NE | H | L | NE | day 10 | none |
| 4 | day 5 | SCC | ovoid | sH | I | NE | H | L | NE | day 12 | none |
| 5 | day 3 | SCC | ovoid | H | sL | none | H | L | NE | day 11 | none |
| 6 | day 4 | SCC | ovoid | sH | I | NE | H | L | NE | day 28 | none |
| 7 | day 5 | SCC | ovoid | sH | sL | NE | H | L | NE | day 32 | none |
| 8 | day 2 | SCC | ovoid | sH | I | NE | H | L | NE | day 27 | none |
| 9 | day 3 | SCC | ovoid | H | L | none | H | L | NE | day 14 | none |
| 10 | day 3 | SCC | extended | sH | sL | NE | H | L | NE | day 10 | none |
| 11 | day 5 | SCC | ovoid | sH | I | none | H | L | NE | day 25 | none |
| 12 | day 6 | SCC | ovoid | sH | sL | none | H | L | NE | day 15 | none |
| 13 | day 1 | SCC | ovoid | sH | I | NE | H | L | NE | day 17 | none |
| 14 | day 4 | SCC | ovoid | sH | sL | none | H | L | NE | day 14 | none |
| 15 | day 3 | SCC | ovoid | H | L | none | H | L | NE | day 16 | none |
scan date from the initial symptoms, scan date from the initial MRI. T2W T2-weighted image, T1WI T1-weighted image, Gd gadolinium enhancement, DWI diffusion weighted imaging, ADC apparent diffusion coefficient, DTI diffusion tensor imaging, SCC splenium of the corpus callosum, H high intensity, L low intensity, I isointensity, sH slight high intensity, sL slight low intensity, NE not examined